Align Technology, Inc. (NasdaqGS: ALGN)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Align Technology, Inc. (“Align” or “Company”) (NasdaqGS: ALGN) and several officers and directors for acts taken during the period of July 25, 2018 and October 24, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Align.  If you are an affected Align shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750.  There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934.  Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (1) that the Company would offer higher discounts to promote Invisalign; (2) that the promotions would materially impact revenue; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

On October 24, 2018, Align announced its Q3 2018 financial results disclosing more than a 6% decrease in its Invisalign Average Selling Price. That same day, Align also announced that its Chief Marketing Officer would “reduce his responsibilities and transition to a part-time position.” When this news was revealed to the market, Align’s stock dropped 20%.

The Briscoe Law Firm, PLLC is a full-service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Penn Virginia Corporation (NASDAQ: PVAC)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Penn Virginia Corporation (“Penn Virginia”) (NASDAQ: PVAC) concerning the acquisition by Denbury Resources Inc. (“Denbury”) (NYSE: DNR). Under the terms of the agreement, valued at approximately $1.7 billion, Penn Virginia shareholders will only receive 12.4 shares of Denbury and $25.86 in cash per Penn Virginia share owned. The consideration is significantly lower than at least one analyst’s estimated value of $110.00.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether Penn Virginia’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of Penn Virginia could be as high as $110.00 per share.

The Briscoe Law Firm, PLLC is a full-service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters, including claims of investor and stockholder fraud, shareholder derivative suits, and securities class actions.